VIDEO: RA patients on subcutaneous methotrexate avoid biologics
LONDON – Subcutaneous methotrexate monotherapy may be more effective at helping recently diagnosed patients with rheumatoid arthritis avoid biologic therapy, compared with similar patients on oral...
Source: Family Practice News - Category: Primary Care Source Type: news
More News: Arthritis | Family Practices | Methotrexate | Primary Care | Rheumatoid Arthritis | Rheumatology